Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    ASH
    2019
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

CAR T-cells

3:05
Predicting MM response to cellular and immunotherapies
Paola Neri
2:25
Increase in cancer patient transfers to the ICU: what does it come down to?
Michael von Bergwelt
2:33
EuroCARTForce: a platform for progress
Michael von Bergwelt
1:14
Preparing the critical care workforce for CAR-T
Michael von Bergwelt
1:10
ICU admission in CAR-T treated patients
Élie Azoulay
1:15
How could CAR-T affect transplantation in R/R lymphomas?
Robin Sanderson
2:07
CAR-T side effects: CRS, neutropenic fever & MAS/HLH
Sandrine Valade
2:12
Improving management of adverse events in CAR-T patients
Élie Azoulay
2:51
CAR T-cell therapy: CRS and adverse effects
Michel Sadelain
1:04
What to expect at the upcoming EMBT-EHA CAR-T Meeting
Orla Stewart
9:35
Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells
Kanti Rai
1:07
Sequential therapy and drug resistance in CLL in the era of targeted agents
Stephan Stilgenbauer
2:11
Cellular therapies in CLL: from transplant to CAR T-cells?
Jennifer Brown
3:00
CAR T-cells for multiple myeloma: update & what’s in store for ASH 2018
Jesús Berdeja
2:42
Toxicity profile for CAR T-cells in multiple myeloma
Jesús Berdeja
11:58
iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine
Anas Younes et al.
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 13
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy